Alliance Healthcare "continues to defend" itself against UK charges of infringing competition law in deals to acquire the antibiotic Nitrofurantoin, according to a US securities filing submitted by AmerisourceBergen, which plans to buy Alliance.
AmerisourceBergen agreed in January to acquire the majority of Alliance Healthcare from peer Walgreens Boots Alliance for